- Principal Investigator (PI) Handbook
- On-line Training
- Office of Grants & Contracts Administration
- Research Integrity & Compliance
- Office of Research and Innovation (ORI) - supported Intramural Grants & Awards
- Innovation and Commercialization
Revised Common Rule Information
On January 21, 2019, OHRP released revisions to the Common Rule (45 CFR 46) - the federal regulations that govern human subjects research. Review the following information to determine how this will impact your research. Download PDF.
|Please join us to learn more about the revised regulations for human subjects research. The sessions will also cover topics including (but not limited to) navigating Cayuse IRB submissions, classroom projects, consent processes, and collaborative research. Sessions are open to all UNT faculty, staff, and students. RSVP to email@example.com with your name and the session you plan to attend.|
|Session 1: Thursday, February 21, 2019, 11:00 AM – 12:00 PM, Union Room 394
Session 2: Thursday, February 21, 2019 2:00 PM – 3:00 PM, Union Room 394
Session 3: Wednesday, February 27, 2019, 9:30 AM – 10:30 AM, Union Room 381
Session 4: Wednesday, February 27, 2019, 3:30 PM – 4:30 PM, Union Room 381
SUMMARY OF MAJOR CHANGES TO THE COMMON RULE
- The definition for “research” has changed.
Research means a systematic investigation, including research development, testing, and evaluation, designed to develop or contribute to generalizable knowledge. Activities that meet this definition constitute research for purposes of this policy, whether or not they are conducted or supported under a program that is considered research for other purposes.
Some activities are deemed not to be research:
- Scholarly and journalistic activities (e.g., oral history, journalism, biography, literary criticism, legal research, and historical scholarship), including the collection and use of information, that focus directly on the specific individuals about whom the information is collected. *Please consult the Office of Research Integrity and Compliance by sending an e-mail to firstname.lastname@example.org or calling 940-565-4643 for guidance if you believe your projects falls under these activities.
- Public health surveillance activities, including the collection and testing of information or biospecimens, conducted, supported, requested, ordered, required, or authorized by a public health authority.
- Collection and analysis of information, biospecimens, or records by or for a criminal justice agency for activities authorized by law or court order solely for criminal justice or criminal investigative purposes.
- Authorized operational activities (as determined by each agency) in support of intelligence, homeland security, defense, or other national security missions.
- The definition of “Human Subject” has changed to include biospecimens.
Human subject is defined as a living individual about whom an investigator conducting research:
- Obtains information or biospecimens through intervention or interaction with the individual, and uses, studies, or analyzes the information or biospecimens;
- Obtains, uses, studies, analyzes, or generates identifiable private information or identifiable biospecimens.
- Identifiable private information is private information for which the identity of the subject is or may readily be ascertained by the investigator or associated with the information.
- An identifiable biospecimen is a biospecimen for which the identity of the subject is or may readily be ascertained by the investigator or associated with the biospecimen.
- Exempt Categories
- Several changes were made to the Exempt Categories. Please review the updated Exempt Categories here.
- Please note: Two additional exemption categories (Category 7 and 8), both involving broad consent, are included in the revisions to the Common Rule. UNT has chosen not to utilize these categories at this time.
- The updated regulations require that certain clinical trial consent forms be posted on a government website (clinicaltrials.gov). *Please contact email@example.com or 940-565-4643 to determine if this applies to your study or to register for an account on clinicaltrials.gov.
- The definition of clinical trial was revised as follows:
- The definition of Clinical Trial is: A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of the interventions on biomedical or behavioral health related outcomes.
- Vulnerable Populations Changes
- The revisions added “Economically or Educationally Disadvantaged Persons”, removed “Pregnant Women” and replaced “Handicapped” with “individuals with Impaired Decision-Making Capacity”.
- Changes to Consent Process and Forms
- Consent documents must begin with concise and focused Key Information to assist subjects with making a decision about participation.
- Key Information must be organized in a way that facilitates a prospective subject’s or legally authorized representative’s understanding of the reasons why an individual might or might not want to participate in the research.
- Additional elements of informed consent are included for applicable studies, including items such as whether a study includes whole genome sequencing, or whether clinically relevant results will be returned to subjects.
- Updated templates can be found on the ORIC webpage here.